Evaluating only Arivale’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. That’s exactly how it died.
Key Events Timeline
FOUNDING
Arivale founded
DOWN ROUND
Down round or bridge financing
SHUTDOWN
Silent Shutdown: Arivale ceases operations
Full Analysis
Free · no account needed
Documented cause
Arivale was a precision medicine startup co-founded by genomics pioneer Lee Hood. The service combined genetic testing, blood biomarkers, gut microbiome analysis, and personalized health coaching to create individualized wellness programs. Scientifically, the approach was ahead of its time — enrollees showed measurable health improvements. Commercially, it was impossible to scale: the cost to deliver the service ($3,500/year per customer) consistently exceeded what the market would pay. After 4 years, $50M raised, and over 5,000 enrolled customers, Arivale shut down in April 2019 with less than a week's notice to employees. The founders were publicly transparent: 'the science was right, the business model wasn't.'
Lesson
“In healthcare, clinical validity and commercial viability are separate problems. A service can be scientifically sound and economically unviable simultaneously — and raising more money doesn't solve the second.”
Failure anatomy
Collapse type
Silent Shutdown
🐌 LOW
Moat type
Scientific IP + Longitudinal Health Data
Fatal mistake
Cost to deliver exceeded willingness to pay at any viable scale